Atria Wealth Solutions’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,641
| Closed | -$369K | – | 1936 |
|
|
2023
Q1 | $369K | Sell |
3,641
-12
| -0.3% | -$1.22K | 0.01% | 1302 |
|
|
2022
Q4 | $436K | Buy |
3,653
+56
| +2% | +$6.69K | 0.01% | 1151 |
|
|
2022
Q3 | $382K | Sell |
3,597
-431
| -11% | -$45.8K | 0.01% | 1162 |
|
|
2022
Q2 | $393K | Sell |
4,028
-568
| -12% | -$55.4K | 0.01% | 1055 |
|
|
2022
Q1 | $431K | Buy |
+4,596
| New | +$431K | 0.01% | 1147 |
|